About this trial
Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.
Eligibility criteria
Qualifiers
Age ≥18 years old
Presented with myocardial infarction, including NSTEMI and STEMI
Undergoing successful percutaneous coronary intervention.
Disqualifiers
Subjects who decline protocol-mandated follow-up or withhold informed consent.
Individuals whose expected survival is < 1 year.
Trial design
Treatments tested in this trial
- Percutaneous coronary intervention